Matrix metalloproteinases in peripheral vascular disease
Authors:
- Robert W. ThompsonRTRobert W. Thompson
- Bart E. MuhsBMBart E. Muhs
- Peter C. BrooksPBPeter C. Brooks
- Paul J. GagnePGPaul J. Gagne
- 1 April 2007
- journal article
- review article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 45 (4) , 849-857
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Mortality and Size of Abdominal Aortic Aneurysm at Long-Term Follow-Up of Patients Not Treated Surgically and Treated With and Without StatinsThe American Journal of Cardiology, 2006
- Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularizationThrombosis and Haemostasis, 2006
- Temporal Exposure of Cryptic Collagen Epitopes within Ischemic Muscle during Hindlimb ReperfusionThe American Journal of Pathology, 2005
- Coronary drug-eluting stent development: Issues in trial designAmerican Heart Journal, 2005
- Implante de stent eluído com batimastat para o tratamento da doença arterial coronariana: resultados do estudo piloto brasileiroArquivos Brasileiros de Cardiologia, 2005
- Activities of the Matrix Metalloproteinase Stromelysin-2 (MMP-10) in Matrix Degradation and Keratinocyte Organization in Wounded SkinMolecular Biology of the Cell, 2004
- Metalloproteinase inhibitor attenuates neointima formation and constrictive remodeling after angioplasty in rats: augmentative effect of αvβ3 receptor blockadeAtherosclerosis, 2002
- Generation of Monoclonal Antibodies to Cryptic Collagen Sites by Using Subtractive ImmunizationHybridoma, 2000
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- Compensatory Enlargement of Human Atherosclerotic Coronary ArteriesNew England Journal of Medicine, 1987